‘Ottava’ has been given market authorisation for use in multiple general surgery procedures within the upper abdomen.
Healthcare giant Johnson & Johnson has been granted ‘de novo’ approval by the US Food and Drug Administration (FDA) for what the company said is the world’s first table-integrated soft tissue robotic surgical system.
‘Ottava’ has been given market authorisation for use in multiple general surgery procedures within the upper abdomen, including gastric bypasses, gastrectomies, appendectomies and hiatal hernia repair.
When integrated into an operating theatre, the system’s four robotic arms occupy up to 50pc less space than ‘boom- and cart-mounted’ solutions for such environments, the company said. The system can also be programmed to help simplify setup and breakdown of an operating theatre, or manipulate the positioning of a patient during a procedure.
Ottava also features a curated range of surgical tools and has its own “digital ecosystem” to support surgeons working with it, according to Johnson & Johnson.
